P3 Health Partners is a Henderson-based, physician-led population-health operator that takes global capitation risk on Medicare Advantage members through affiliated primary-care physicians. The latest quarter is the first time the platform has shown both consolidated net income and a large swing in adjusted earnings after a multi-year prune of unprofitable contracts under chief executive Aric Coffman. Reported adjusted earnings before interest, taxes, depreciation, and amortization reached $54 million. That headline still includes a large block of payer settlements and prior-year claims development, so the operating question is whether the remaining book now earns its keep once those items fade. Common equity is a residual claim behind high-coupon preferred stock held by Chicago Pacific Founders, the same sponsor that recapitalized the notes in the spring and still sits at the center of every liquidity decision.
At-risk membership contracted about one tenth from the year-ago period as management exited weaker payer and provider combinations. Revenue still rose because capitated revenue per member increased at a mid-teens rate on better network rates, risk-score documentation, and mix. Medical margin on the reported basis reached $98 million. Strip the settlements and the same line is $53 million, which is the figure that actually tests whether the remaining book can fund corporate overhead. First-half cash from operations was a large outflow even as the income statement turned profitable, which is the tell that claims timing and working-capital swings still dominate the residual claim. The income-statement turn is real. The cash conversion is not yet.
Management raised full-year adjusted-earnings guidance into a band whose midpoint sits well above the first-quarter outlook. The raise explicitly folds in first-half settlements, so it is not a clean read on second-half run-rate. Unrestricted cash at mid-year was $21 million against a working-capital deficit that still runs to hundreds of millions, and the company again stated substantial doubt about continuing as a going concern. The next several quarters resolve a single question: whether underlying medical margin stays positive through seasonal cost inflation without another settlement gift, and whether that margin converts into cash before the preferred coupons and the sponsor's next funding round reset the common.